T. Kubo

Fc receptor targeting in the treatment of allergy, autoimmune diseases and cancer.

A. Nakamura, T. Takai, T. Kubo, 2008, Advances in experimental medicine and biology.

Augmented TLR9-induced Btk activation in PIR-B–deficient B-1 cells provokes excessive autoantibody production and autoimmunity

S. Akira, M. Ono, A. Nakamura, 2009, The Journal of experimental medicine.